# Tectonic Therapeutic, Inc. (TECX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Tectonic Therapeutic, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TECX/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-076793 (https://www.sec.gov/Archives/edgar/data/1681087/000119312526076793/tecx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TECX/mda/fy2024/): filed 2025-03-20; accession 0000950170-25-042648 (https://www.sec.gov/Archives/edgar/data/1681087/000095017025042648/tecx-20241231.htm)
- [FY 2023 MD&A](/company/TECX/mda/fy2023/): filed 2024-03-14; accession 0000950170-24-031635 (https://www.sec.gov/Archives/edgar/data/1681087/000095017024031635/avro-20231231.htm)
- [FY 2022 MD&A](/company/TECX/mda/fy2022/): filed 2023-03-23; accession 0000950170-23-009527 (https://www.sec.gov/Archives/edgar/data/1681087/000095017023009527/avro-20221231.htm)
- [FY 2021 MD&A](/company/TECX/mda/fy2021/): filed 2022-03-17; accession 0001564590-22-010895 (https://www.sec.gov/Archives/edgar/data/1681087/000156459022010895/avro-10k_20211231.htm)

Back to /company/TECX/